Quest Diagnostics, Inc.

Quest Diagnostics, Inc.DGX

Dividend Summary

The next Quest Diagnostics, Inc. dividend went ex 15 days ago for 56c and will be paid tomorrow.
The previous Quest Diagnostics, Inc. dividend was 56c and it went ex 4 months ago and it was paid 3 months ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 3.1.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid Declared
Type Quarterly Quarterly
Per share 56c 56c
Declaration date 18 May 2020 (Mon) 18 Aug 2020 (Tue)
Ex-div date 07 Jul 2020 (Tue) 05 Oct 2020 (Mon)
Pay date 22 Jul 2020 (Wed) 21 Oct 2020 (Wed)

Enter the number of Quest Diagnostics, Inc. shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
98%
Our premium tools have predicted Quest Diagnostics, Inc. with 98% accuracy.
Dividend Yield Today
1.9%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Quest Diagnostics, Inc.
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Forecast Quarterly 13 Nov 2024 13 Jan 2025 28 Jan 2025 USD Sign up
Forecast Quarterly 13 Aug 2024 30 Sep 2024 15 Oct 2024 USD Sign up
Forecast Quarterly 13 May 2024 02 Jul 2024 17 Jul 2024 USD Sign up
Forecast Quarterly 25 Jan 2024 01 Apr 2024 16 Apr 2024 USD Sign up
Forecast Quarterly 15 Nov 2023 08 Jan 2024 23 Jan 2024 USD Sign up
Forecast Quarterly 15 Aug 2023 02 Oct 2023 18 Oct 2023 USD Sign up
Forecast Quarterly 15 May 2023 03 Jul 2023 19 Jul 2023 USD Sign up
Forecast Quarterly 26 Jan 2023 03 Apr 2023 18 Apr 2023 USD Sign up
Forecast Quarterly 16 Nov 2022 09 Jan 2023 25 Jan 2023 USD Sign up
Forecast Quarterly 16 Aug 2022 03 Oct 2022 19 Oct 2022 USD Sign up
Forecast Quarterly 16 May 2022 05 Jul 2022 20 Jul 2022 USD Sign up
Forecast Quarterly 27 Jan 2022 04 Apr 2022 19 Apr 2022 USD Sign up
Forecast Quarterly 17 Nov 2021 10 Jan 2022 26 Jan 2022 USD Sign up
Forecast Quarterly 17 Aug 2021 04 Oct 2021 20 Oct 2021 USD Sign up
Forecast Quarterly 17 May 2021 06 Jul 2021 21 Jul 2021 USD Sign up
Forecast Quarterly 28 Jan 2021 05 Apr 2021 20 Apr 2021 USD Sign up
Forecast Quarterly 18 Nov 2020 11 Jan 2021 27 Jan 2021 USD Sign up
Declared Quarterly 18 Aug 2020 05 Oct 2020 21 Oct 2020 USD 56c 56c 😄
Paid Quarterly 18 May 2020 07 Jul 2020 22 Jul 2020 USD 56c 56c 😄
Paid Quarterly 30 Jan 2020 06 Apr 2020 21 Apr 2020 USD 58c 56c 😃
Paid Quarterly 20 Nov 2019 13 Jan 2020 29 Jan 2020 USD 56c 53c 😊
Paid Quarterly 15 Aug 2019 03 Oct 2019 21 Oct 2019 USD 53c 53c 😄
Paid Quarterly 14 May 2019 05 Jul 2019 22 Jul 2019 USD 53c
Paid Quarterly 01 Mar 2019 05 Apr 2019 22 Apr 2019 USD 53c
Paid Quarterly 28 Nov 2018 14 Jan 2019 30 Jan 2019 USD 53c
Paid Quarterly 17 Aug 2018 04 Oct 2018 22 Oct 2018 USD 50c
Paid Quarterly 14 May 2018 06 Jul 2018 23 Jul 2018 USD 50c
Paid Quarterly 01 Feb 2018 03 Apr 2018 18 Apr 2018 USD 50c
Paid Quarterly 29 Nov 2017 08 Jan 2018 24 Jan 2018 USD 45c
Paid Quarterly 18 Aug 2017 02 Oct 2017 18 Oct 2017 USD 45c
Paid Quarterly 16 May 2017 06 Jul 2017 24 Jul 2017 USD 45c
Paid Quarterly 21 Feb 2017 03 Apr 2017 19 Apr 2017 USD 45c
Paid Quarterly 06 Jan 2017 25 Jan 2017 USD 45c
Paid Quarterly 17 Aug 2016 30 Sep 2016 19 Oct 2016 USD 40c
Paid Quarterly 18 May 2016 01 Jul 2016 20 Jul 2016 USD 40c
Paid Quarterly 04 Apr 2016 20 Apr 2016 USD 40c
Paid Quarterly 04 Dec 2015 08 Jan 2016 27 Jan 2016 USD 38c
Paid Quarterly 18 Aug 2015 02 Oct 2015 21 Oct 2015 USD 38c
Paid Quarterly 15 May 2015 06 Jul 2015 22 Jul 2015 USD 38c
Paid Quarterly 29 Jan 2015 06 Apr 2015 22 Apr 2015 USD 38c
Paid Quarterly 04 Dec 2014 09 Jan 2015 28 Jan 2015 USD 33c
Paid Quarterly 15 Aug 2014 03 Oct 2014 22 Oct 2014 USD 33c
Paid Quarterly 21 May 2014 07 Jul 2014 23 Jul 2014 USD 33c
Paid Quarterly 29 Jan 2014 04 Apr 2014 23 Apr 2014 USD 33c
Paid Quarterly 05 Dec 2013 03 Jan 2014 22 Jan 2014 USD 30c
Paid Quarterly 20 Aug 2013 27 Sep 2013 16 Oct 2013 USD 30c
Paid Quarterly 21 May 2013 28 Jun 2013 17 Jul 2013 USD 30c
Paid Quarterly 26 Feb 2013 28 Mar 2013 16 Apr 2013 USD 30c
Paid Quarterly 16 Nov 2012 09 Jan 2013 28 Jan 2013 USD 30c
Paid Quarterly 27 Sep 2012 16 Oct 2012 USD 17c
Paid Quarterly 29 Jun 2012 18 Jul 2012 USD 17c
Paid Quarterly 30 Mar 2012 17 Apr 2012 USD 17c
Year Amount Change
2006 0.0c
2007 0.0c
remove
0%
2008 0.0c
remove
0%
2009 0.0c
remove
0%
2010 0.0c
remove
0%
2011 0.0c
remove
0%
2012 81.0c
arrow_upward
100%
2013 120.0c
arrow_upward
48.1%
2014 132.0c
arrow_upward
10.0%
2015 152.0c
arrow_upward
15.2%
2016 165.0c
arrow_upward
8.6%
2017 180.0c
arrow_upward
9.1%
2018 203.0c
arrow_upward
12.8%
2019 212.0c
arrow_upward
4.4%
2020 Sign Up Required
2021 Sign Up Required
2022 Sign Up Required
2023 Sign Up Required
2024 Sign Up Required

Quest Diagnostics, Inc. Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
1.9%
Optimized Yield
Sign Up Required
52 Week High
4.7% on 05 April 2020
52 Week Low
1.9% on 22 July 2020
Next Ex-Div-Date Countdown
Sign Up Required

About Quest Diagnostics, Inc.

Quest Diagnostics Incorporated, incorporated on September 20, 1996, is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers.

Diagnostic Information Services

The Company provides information and insights based on routine, non-routine and advanced clinical testing and anatomic pathology testing, and related services, offering customers the test menu. The Company offers testing solutions, including services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and offer tests in various fields, including endocrinology, immunology, neurology and oncology. It is focused on providing solutions and insights to its customers, based on the testing that it performs and its medical, information and connectivity assets. It provides integrated, diagnostic information services that include both anatomic pathology and clinical laboratory testing, enabling it to offer patients and clinicians a complete analysis. The Company offers access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers, and phlebotomists in physician offices. It provides interpretive consultation through medical and scientific staffs in the industry.

The Company is a provider of infectious disease diagnostic information services. It also provides diagnostic solutions for infectious diseases, including its Focus Diagnostics offerings for Zika, West Nile Virus, Severe acute respiratory syndrome (SARS) and Influenza A H1N1. It is engaged in the neurology diagnostics market, in cardiovascular diagnostic information services, including its CardioIQ offering, and in cancer diagnostics, including its QuestVantage offerings. It is engaged in providing testing for the detection of employee use of drugs of abuse, offering a range of solutions, including urine, hair, blood and oral fluid tests. The Company is a provider of biometric wellness screenings, flu shots and related preventative services. It offers biometric wellness screenings to employer populations through its patient service centers and on-site through its network of mobile examiners and nurses. In addition to a range of screening options, it also offers Blueprint for Wellness and private label reporting, analytics and incentive management services. These services are sold directly to employers and through reseller partnerships with various health plans.

The Company's Quanum health information technology solutions help healthcare organizations and clinicians empower health through diagnostic insights by taking advantage of its information assets, including various years of test result data, and its technology prowess, including its history of providing information technology for diagnostic information services. It provides diagnostic information services in various markets outside the United States. It has laboratory facilities in Gurgaon, India; Mexico City, Mexico, and San Juan, Puerto Rico. It also provides testing services, and inpatient anatomic pathology and medical director services, at hospital laboratories. Its services primarily are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Diagnostic Solutions

The Company is a provider of risk assessment services for the life insurance industry. In addition, it offers healthcare organizations and clinicians health information technology solutions. ExamOne is a provider of risk assessment services to the life insurance industry in North America. It also provides risk assessment services for insurance companies operating outside North America. Its risk assessment services comprise underwriting support services, including data gathering, paramedical examinations and clinical laboratory testing and analytics, designed to assist life insurance companies objectively to evaluate the mortality risks of applicants. As of December 31, 2016, specimen collections and paramedical examinations were performed by its network of paramedical examiners at the applicant's home or workplace, but they also were offered at approximately 600 company patient service centers in the United States and approximately 120 additional locations in North America.

The Company's healthcare information technology offerings include its Quanum EHR product and its ChartMaxx enterprise content management system for hospitals. Its Quanum EHR offering enables clinicians to generate a complete record of a clinical patient encounter, automates and streamlines the clinician's workflow, provides clinical decision support tools, captures patient encounter notes and lab and radiology results and enables communication with patients and other clinicians. Its MyQuest patient healthcare portal enables patients to manage their healthcare and medical information and, among other things, use their smartphone or computer to receive and archive their Quest Diagnostics test results, find a Quest Diagnostics location and schedule appointments.

The Company competes with Laboratory Corporation of America Holdings, Inc.

Sector
Support Services
Country
United States
Share Price
$120.83 (yesterday's closing price)
Shares in Issue
135 million
Market Cap
$16.3bn
Dividend Cover
How many times is the dividend covered by company income. A cover of 1 means all income is paid out in dividends
3.1
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
8
Market Indices
S&P 500
No articles found